Survivin level in keloids before and after treatment with FK506 (tacrolimus) versus intralesional steroid injection, correlating its level with clinical and histopathological treatment outcome | Samaa Kamar

Survivin level in keloids before and after treatment with FK506 (tacrolimus) versus intralesional steroid injection, correlating its level with clinical and histopathological treatment outcome

Citation:: Ali, S. A., T. A. E. A. Raheem, M. M. Fawzy, S. S. Kamar, and A. M. Mokhtar, "Survivin level in keloids before and after treatment with FK506 (tacrolimus) versus intralesional steroid injection, correlating its level with clinical and histopathological treatment outcome", Journal of American Science, vol. 17, issue 8, pp. 72-83, 2021.